SALEKI-GERHARDT AZITA (CIK 1563545) reported 14 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-08). Recent activity: Buy ENTG (1,412 shares), Sell ABBV (16,309 shares), Buy ABBV (17,041 shares), Buy ABBV (6,058 shares), Buy ABBV (7,074 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-08 | ENTEGRIS INC (ENTG) | Director | Buy | 1,412 | $0 |
| 2026-03-03 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Sell | 16,309 | $3.8M |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 17,041 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 6,058 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 7,074 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 6,638 | $0 |
| 2025-08-14 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 42,370 | $2.3M |
| 2025-08-14 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Sell | 42,370 | $8.4M |
| 2025-04-25 | ENTEGRIS INC (ENTG) | Director | Buy | 2,897 | $0 |
| 2025-03-04 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Sell | 17,056 | $3.5M |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 17,986 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 7,378 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 6,060 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | Buy | 7,074 | $0 |
Source: SEC Form 4 filings · as of 2026-05-08